Compare
Tamboran Resources Corp vs Abundia Global Impact Group, Inc. vs Prairie Operating Co. vs Arcadia Biosciences, Inc.
| Latest fiscal year | Tamboran Resources Corp TBN | Abundia Global Impact Group, Inc. AGIG | Prairie Operating Co. PROP | Arcadia Biosciences, Inc. RKDA |
|---|---|---|---|---|
| Year ended | 2025-06-30 | 2025-12-31 | 2025-12-31 | 2025-12-31 |
| Revenue | $0 | $410.6K | $241.65M | $4.86M |
| Revenue growth (YoY) | n/a | -26.7% | n/m | -3.7% |
| Gross margin | n/a | n/a | n/a | 36.2% (computed) |
| Operating margin | n/a | n/m | 27.1% | -51.5% |
| Net margin | n/a | n/m | 13.3% | -48.1% |
| Net income | -$36.90M | -$29.45M | $32.05M | -$2.34M |
| EPS (Diluted) | -$2.52 | -$0.90 | -$1.35 | -$1.71 |
| Operating cash flow | -$29.64M | -$8.05M | $153.90M | -$4.74M |
| Free cash flow | n/a | -$16.71M | n/a | -$4.74M |
| Cash & equivalents | $39.44M | $4.62M | $20.0K | $259.0K |
| Total assets | $446.46M | $31.86M | $944.55M | $6.55M |
| Total liabilities | $57.01M | $12.84M | $678.24M | $2.41M |
| Shareholders' equity | $287.72M | $19.01M | $130.16M | $4.14M |
| Return on year-end equity | -12.8% | -154.9% | 24.6% | -56.5% |
| Shares outstanding | 16.72M | 36.92M | 62.50M | 1.37M |
Revenue, most recent five fiscal years
| Fiscal year | Tamboran Resources Corp | Abundia Global Impact Group, Inc. | Prairie Operating Co. | Arcadia Biosciences, Inc. |
|---|---|---|---|---|
| Latest | $0 Ended 2025-06-30 | $410.6K Ended 2025-12-31 | $241.65M Ended 2025-12-31 | $4.86M Ended 2025-12-31 |
| 1 year earlier | $0 Ended 2024-06-30 | $560.2K Ended 2024-12-31 | $7.94M Ended 2024-12-31 | $5.04M Ended 2024-12-31 |
| 2 years earlier | n/a | $794.0K Ended 2023-12-31 | $1.55M Ended 2023-12-31 | $4.45M Ended 2023-12-31 |
| 3 years earlier | n/a | $1.64M Ended 2022-12-31 | $517.6K Ended 2022-12-31 | $7.42M Ended 2022-12-31 |
| 4 years earlier | n/a | $1.33M Ended 2021-12-31 | $369.8K Ended 2021-12-31 | $6.78M Ended 2021-12-31 |